Rucaparib is an orally available potent selective small-molecule inhibitor of poly(ADP-ribose) polymerase (PARP) 1 and 2. Rucaparib induces synthetic lethality in cancer cells defective in the ...
SALT LAKE CITY, UT--(Marketwired - Apr 3, 2014) - ADP® AdvancedMD, a leader in all-in-one, cloud electronic health record (EHR), practice management, and medical scheduling software as well as medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results